Daniel Grunder
Presidente en GoodWind Holding GmbH .
Cargos activos de Daniel Grunder
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Welle Holding AG + Co. KG
Welle Holding AG + Co. KG Home FurnishingsConsumer Durables Welle Holding AG + Co. KG manufactures wooden and upholstered furniture. It provides furniture for kitchen, babies, children and teenagers. The company is headquartered in Paderborn, Germany. | Director/Miembro de la Junta | - | - |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Director/Miembro de la Junta | - | - |
GoodWind Holding GmbH
GoodWind Holding GmbH Financial ConglomeratesFinance GoodWind Holding GmbH is a Swiss company that specializes in the acquisition, management, and sale of securities and similar assets. The private company is based in Baar, Switzerland. The company also handle financing and fiduciary transactions. | Presidente | - | - |
Historial de carrera de Daniel Grunder
Estadísticas
Internacional
Suiza | 3 |
Alemania | 2 |
Operativa
Director/Board Member | 2 |
Chairman | 1 |
Sectorial
Consumer Durables | 2 |
Health Technology | 2 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Welle Holding AG + Co. KG
Welle Holding AG + Co. KG Home FurnishingsConsumer Durables Welle Holding AG + Co. KG manufactures wooden and upholstered furniture. It provides furniture for kitchen, babies, children and teenagers. The company is headquartered in Paderborn, Germany. | Consumer Durables |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Health Technology |
GoodWind Holding GmbH
GoodWind Holding GmbH Financial ConglomeratesFinance GoodWind Holding GmbH is a Swiss company that specializes in the acquisition, management, and sale of securities and similar assets. The private company is based in Baar, Switzerland. The company also handle financing and fiduciary transactions. | Finance |
- Bolsa de valores
- Insiders
- Daniel Grunder
- Experiencia